Amphastar Pharmaceuticals Discusses Baqsimi and Primatene Growth at Needham Conference
Amphastar Pharmaceuticals highlighted the growth of its products Baqsimi and Primatene Mist at the Needham Conference. Baqsimi is expected to generate $175M in sales this year, triggering a $100M payment, while Primatene Mist is projected to grow by high single to low double digits. The company also outlined its financial position and future pipeline developments.
Tickers: $AMPH
Topics: Baqsimi financial performance M&A potential pharmaceuticals pipeline development Primatene Mist